
Our product IHRA can identify early signs of Type 2 Diabetes and Hypertension, non-invasivly11-50 Employees
- B2C
- B2B
- Early StageStartup in initial stages
Aarca Research careers
IHRA (Intelligent Health Risk Assessment) is a first-of-its-kind prognostic screening solution for Type 2 Diabetes and Hypertension, using non-invasive technology. Our deep-tech product identifies if you are showing early indications of these conditions. This point of care product is a portable primary care solution that can also be used in large-scale preventive healthcare screenings. Contact us today to learn more! #ForAHealthierTomorrow #GoLongOnHealth
Aarca Research hasn't added any jobs yet
Get notified when Aarca Research posts new jobs.
Gayathri Choda
Founder & CEO @Aarca Research, @Digitant
Valuation
$7M
Funded over
2 rounds
Latest round
Seed (Dec 2022)
HootBoard • Princeton • $150k – $225k • No equity • today
Sword Health • New York City • $58k – $91k • 1 week ago
Modea • Nashville • $150k – $185k • 1 week ago
Experion Technologies • Kansas City • 2 weeks ago
mPulse Mobile • Los Angeles • 2 weeks ago

